Bret Marin

Bret Marin has extensive experience in the pharmaceutical industry, having worked in various roles over the years. Bret is currently employed at Allakos Inc since 2020, where they hold the position of Director, Drug Product, Site Management. Prior to this, they worked at Immunomedics as an Associate Director, External Manufacturing from 2019 to 2020.

Before joining Immunomedics, Bret Marin worked at Genentech for six years from 2013 to 2019. During their time there, they served as the Principal Site Manager, Contract Manufacturing. In this role, they were responsible for managing contract manufacturing activities for commercial products at third-party organizations. Bret handled tasks such as CMO selection, process technology transfer, routine manufacturing, and site decommissioning. Bret also maintained alignment between Genentech's objectives and plans and those of the CMO.

Before Genentech, Bret Marin worked at Solstice Neurosciences as a Senior Manager, Production Operations from 2008 to 2013. Prior to that, they were an Associate Scientist at Scios Inc. (Johnson & Johnson company) from 2004 to 2007. Bret started their career as a Research Associate at PPD Discovery from 2000 to 2001 and also worked at Scios as a Sr. Dev. Assoc. from 1995 to 1998.

Bret Marin has a Bachelor of Science (B.Sc.) degree in Cell/Cellular and Molecular Biology from Humboldt State University. Additionally, they hold a Master of Science (M.Sc.) degree in Pharmaceutical Manufacturing from Stevens Institute of Technology. The specific start and end years for these educational experiences are not provided.